BGMS (Bio Green Med Solution, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Bio Green Med Solution, Inc. Common Stock (BGMS) is a publicly traded the market company. As of May 21, 2026, BGMS trades at $0.96 with a market cap of $5.35M and a P/E ratio of -0.15. BGMS moved +1.13% today. Year to date, BGMS is -29.60%; over the trailing twelve months it is flat. Its 52-week range spans $0.73 to $6.70. Rallies surfaces BGMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns BGMS stock?
Rallies tracks hedge fund and 13F ownership for BGMS, including fund holders, share counts, and position changes when data is available.
Yap Kim Choy sold 28.54K (~$48.52K) on Nov 5, 2025.
Yap Kim Choy sold 112.26K (~$202.85K) on Oct 30, 2025.
Kua Khai Loon sold 242.48K (~$436.46K) on Oct 30, 2025.
BGMS Analyst Consensus
BGMS analyst coverage data. Average price target: $0.00.
Common questions about BGMS
Who owns BGMS stock?
Rallies tracks hedge fund and 13F ownership for BGMS, including fund holders, share counts, and position changes when data is available.
Does Rallies show 13F holders for BGMS?
Yes. Rallies tracks hedge fund and 13F ownership data for BGMS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BGMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BGMS. It does not provide personalized investment advice.
